OIS Podcast | Ophthalmology's leading Podcast

OIS Podcast
  • 0.0 (0)
  • Geldanlage
  • Wöchentlich

Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.

  1. 7. Juli

    Trial by Fire: Designing and Executing Ophthalmic Studies That Deliver

    PANELIST (TITLE and AFFILIATION):   Richard L. Beckman, M.D., Principal, RLB, M.D. Consulting, LLC Malvina Eydelman, M.D., CEO, The Collaborative Community on Ophthalmic Innovation MODERATOR: Barbara Wirostko, M.D., FARVO, CMO and Co-Founder, Qlaris Bio  Description: How should you design your first-in-human study? Richard L. Beckman, M.D., principal of RLB, M.D. Consulting, LLC, and Malvina Eydelman, M.D., CEO of the Collaborative Community on Ophthalmic Innovation, sit down on a panel at OIS Ignite 2025, moderated by Barbara Wirostko, M.D., FARVO, CMO and co-founder, Qlaris Bio, to discuss what goes into designing first-in-human studies, including the preclinical work, the right people to advise you, and considering the population and patients. Also, stay tuned for updates on the next OIS Ignite, taking place on March 2027!    In this episode, learn about:   How the FDA can help and if it’s ever “too early” to reach out to them The FDA’s perspective  Establishing a target product profile If a DSMB is recommended for trials   RESOURCES:     Barbara Wirostko: https://ois.net/barbara-wirostko-md-farvo/   Richard L. Beckman: https://ois.net/richard-rick-l-beckman-md/   Malvina Eydelman: https://ois.net/malvina-eydelman/

    Trial by Fire: Designing and Executing Ophthalmic Studies That Deliver

  2. 2. Juni

    Leaving a Global Footprint on Eye Care

    Gordon Bethwaite, head of marketing of eye care at Viatris, joins the Eye on Innovation podcast with host Carey Powers, M.B.A. to discuss Viatris’ footprint and impact on ophthalmology on a global scale. Bethwaite shares details on the company’s overall strategic vision for eye care, their fifth anniversary, and how it handles the “noisy category” that is dry eye.   In this episode, learn about:  Viatris’ acquisitions and license agreements with different companiesWhat Tyrvaya brings to the table for clinicians and patientsHow Viatris is tackling unmet marketsWhat innovation means to Viatris in the context of ophthalmology  RESOURCES:  Carey Powers: https://ois.net/carey-powers/       Gordon Bethwaite: https://ois.net/gordon-bethwaite/

    Leaving a Global Footprint on Eye Care

  3. 11. Mai

    Corneal Health Innovations and Therapeutics

    Rakhi Melvani, M.D., board-certified cornea and cataract and refractive surgeon at Gordon Schanzlin New Vision Institute, joins the Eye on Innovation podcast with host Carey Powers, M.B.A. to discuss innovative corneal treatments and how they’re changing the way patients receive treatment. Their conversation explores the FDA approval of Epioxa, an epithelium-on corneal collagen cross-linking therapy to treat progressive keratoconus, as well as refractive surgery and dry eye therapies.     In this episode, learn about:   Ray tracing-based customization technology and how it’s different from Lasik Collagen mimetic peptides and how they work ST100 and the patients that would benefit from it   RESOURCES:   Carey Powers: https://ois.net/carey-powers/

  4. 14. Apr.

    How Interventional Glaucoma is Advancing Eye Care

    Ehsan Sadri, M.D., CEO and founder of Visionary Eye Institute, joins the Eye on Innovation podcast to discuss the advancements of interventional glaucoma. With host Carey Powers, their conversation delves into how Sadri has changed patient care and management, the advancements he’s most excited for, and his thoughts on those who have yet to adopt interventional glaucoma as a practice mainstay.    In this episode, learn about:   The burden of drops on practices The characteristics to look for when choosing a minimally invasive procedure Metrics to evaluate success for interventional glaucoma procedures How patient education has evolved How interventional glaucoma procedures contribute positively toward patient adherence and engagement   RESOURCES:   Carey Powers: https://ois.net/carey-powers/      Dr. Ehsan Sadri: https://ois.net/ehsan-sadri-md/

    How Interventional Glaucoma is Advancing Eye Care

  5. 13. März

    Tackling New Territory and Forming Partnerships

    Peter Michael Benz, Ph.D., joins The Rob & Jai Show, an edition of the OIS podcast, to discuss Boehringer Ingelheim International GmbH’s ambitious goals for the ophthalmology field, particularly on glaucoma, and the reasons behind the company’s partnership with Ravana Therapeutics, as well as offer advice on what makes for a good partnership.  In this episode of the OIS podcast, learn about:   Boehringer emerging from stealth mode for eye health projects  Their plans for their investments in the U.S. Why it was so important for Boehringer to partner up with Ravana What makes a good partnership RESOURCES:   Dr. Rob Rothman: https://ois.net/robert-rothman-md/  Dr. Jai Parekh: https://ois.net/jai-g-parekh-md-mba/  Dr. Peter Michael Benz: https://ois.net/peter-michael-benz-phd/

    Tackling New Territory and Forming Partnerships

  6. 10. Feb.

    Malvina Eydelman and the Bright Future of Innovation for Ophthalmology

    Malvina Eydelman, M.D., CEO of The Collaborative Community on Ophthalmic Innovation (CCOI), joins The Rob & Jai Show, an edition of the OIS podcast, to discuss what innovation in the industry looks like in the next 30 years—and if we’re hitting a saturation mark. Plus, a deep dive into Eydelman’s career in the FDA, her current role at the CCOI, and a big announcement of her next initiative.    In this episode of the OIS podcast, learn about:   Eydelman’s time at the FDA and the many hats she wore The goal and plans of the CCOI The role of AI in digital management and getting more patients into the system Details about Eydelman’s next big initiative   RESOURCES:   Dr. Rob Rothman: https://ois.net/robert-rothman-md/  Dr. Jai Parekh: https://ois.net/jai-g-parekh-md-mba/   Dr. Malvina Eydelman: https://ois.net/malvina-eydelman/

    Malvina Eydelman and the Bright Future of Innovation for Ophthalmology

  7. 13. Jan.

    Adrienne Graves, Ph.D. on the Future Direction of Ophthalmic Innovation

    Adrienne Graves, Ph.D. returns, this time on The Rob & Jai Show, an edition of the OIS podcast. As a trailblazer of the industry, Dr. Graves shares her insights and lessons learned as a CEO and board member of several companies. She also discusses getting treatment to areas around the world that need it the most, how AI will affect and continue to impact eyecare and healthcare at large, and utilizing ophthalmic data for systemic disease diagnosis and management.    In this episode of the OIS podcast, learn about:   Getting affordable and accessible ophthalmological therapies across the world The differences between being a CEO and a board member The impact of AI on eyecare and how it applies to practices The next hot topic of ophthalmology   RESOURCES:   Dr. Rob Rothman: https://ois.net/robert-rothman-md/  Dr. Jai Parekh: https://ois.net/jai-g-parekh-md-mba/   Adrienne Graves, Ph.D.: https://www.linkedin.com/in/adriennegraves

    Adrienne Graves, Ph.D. on the Future Direction of Ophthalmic Innovation

  8. 12.12.2025

    A Unique Approach to Tackling the Obstacles of Ophthalmology

    Theresa Heah, M.D., MBA, co-founder, vice-chair, and CEO of Eyexora, speaks with host Carey Powers at this year’s Ophthalmology Innovation Summit about her company’s fresh approach to building an ophthalmology company that centralizes R&D, clinical, regulatory, and commercial expertise into a “one-stop shop.” Heah delves into the advantages of the hub and spoke model and how it will help overcome the gaps in the eye care landscape, as well as their plans to expand to the UK.  In this episode of the OIS podcast, learn about:   · Eyexora’s mission as a unique hub and spoke company dedicated to accelerating clinical innovation  ·  The barriers in the ophthalmology field and how Eyexora’s approach will help overcome them  ·  The advantages of building relationships on a global scale  ·  Milestones and scientific areas to look out for in 2026  RESOURCES:   Carey Powers: https://ois.net/carey-powers/   Theresa Heah: https://www.linkedin.com/in/theresaheah   Eyexora: https://eyexora.com/

    A Unique Approach to Tackling the Obstacles of Ophthalmology
Alle anzeigen (434)

Info

Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.

Informationen

Das gefällt dir vielleicht auch